Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Immutep

Tracked across 3 events · 49 articles · First seen Apr 01, 2026 · Last active May 15, 2026

Sentiment
-83
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 -90
Business
Immutep announced the discontinuation of its TACTI-004 Phase III study for non-small cell lung cancer on March 13, 2026, following an interim futility analysis. This news caused Immutep's American Depositary Receipt (ADR) price to fall…
Impact: Immutep's stock price fell significantly after the discontinuation of its TACTI-004 Phase III study, leading to a class action investigation by Rosen Law Firm.
Apr 01, 2026 · 37 articles
2 -70
Business
Rosen Law Firm has announced a class action lawsuit against Immutep, a publicly traded company, on behalf of investors who purchased its American Depositary Receipts between March 24, 2025, and March 12, 2026. The lawsuit…
Impact: Immutep is the defendant in a class action lawsuit alleging false and misleading statements regarding its TACTI004 trial, which could lead to significant financial damages and reputational harm.
May 07, 2026 · 6 articles
4 -90
Business
A class action lawsuit has been filed against Immutep by Pomerantz LLP on behalf of investors. The lawsuit alleges securities fraud and other unlawful business practices by Immutep and its officers/directors. This follows Immutep's announcement…
Impact: Immutep is facing a class action lawsuit due to alleged securities fraud following the discontinuation of its TACTI-004 Phase III study, which caused its ADR price to fall significantly.
May 07, 2026 · 6 articles
NEWSDESK
Track Immutep live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.